Clinical trial

Effect of Omega-3 Fatty Acids on Insulin Sensitivity in Chinese Type 2 Diabetic Patients

NCT01857167

Study summary

ClinicalTrials.gov

Effect of Omega-3 Fatty Acids on Insulin Sensitivity in Chinese Type 2 Diabetic Patients

Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DIETARY_SUPPLEMENT · Unmapped registry intervention Fish Oil Supplementation Find medicine records · Find other trials using this name

DIETARY_SUPPLEMENT · Unmapped registry intervention Flaxseed Oil Supplementation Find medicine records · Find other trials using this name

DIETARY_SUPPLEMENT · Unmapped registry intervention placebo Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2013-06-01

PhaseNA

Conditions

Type 2 Diabetesverified · MONDO: type 2 diabetes mellitus

Insulin Resistanceunresolved

Interventions

Fish Oil SupplementationDIETARY_SUPPLEMENT

Flaxseed Oil SupplementationDIETARY_SUPPLEMENT

placeboDIETARY_SUPPLEMENT

Sponsors & collaborators

Zhejiang Universitylead sponsor

National Natural Science Foundation of Chinacollaborator

Mapped research locations

HangzhouZhejiang, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01857167 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.